TA-GW vaccine for human papillomavirus data

Phase IIa results with the vaccine show good immune response and tolerability, as presented

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE